APEC Meeting Highlights Persistent USChina Trade Divergence Kevin Warsh Takes Helm as Fed Chair Amid Trumps Push for Rate Cuts Markets Expect Extended Pause Quantum Computing Stocks Surge on US Governments 2 Billion Funding Plan OpenAI Emerges as Frontrunner in AI IPO Race Amid Confidential Filing Reports Jim Cramer Suggests Turnaround Strategy for Nike NKE Shares Galeries Lafayette Closes Beijing Store After 13 Years Realigns Strategy for Chinese Market KLIC Q1 2026 Earnings EPS Surges Past Estimates as Semiconductor Demand Holds Steady Root Inc ROOT Q1 2026 Earnings EPS Surges Past Estimates by 1436 Shares Dip Slightly VKTX Q1 2026 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses MYFW Q1 2026 Earnings Strong Earnings Beat with 4279 Surprise CAMT Q1 2026 Earnings EPS Slightly Beats Estimates Stock Advances Fortress Biotech Preferred Stock FBIOP Q4 2025 Earnings EPS Misses Estimates by Over 108 Luda Technology Group LUD Rises 395 Testing Key Resistance at 469 Meritage Homes MTH Edges Higher as Homebuilder Sector Finds Footing WiMi Hologram Cloud Slips Amid Subdued Trading Key Support in Focus Lexeo Therapeutics LXEO Slips 229 as Stock Tests Key Support Levels Wellchange Holdings WCT Edges Higher as Bulls Test Key Resistance Darling Ingredients DAR Edges Higher Key Levels to Watch After a Modest Gain Trinity Biotech TRIB Recovers 397 from Support Approaches Resistance at 075 Richtech Robotics RR Holds Steady Near Key Support Level BrightSpire Capital BRSP Holds Steady at 568 as Trading Range Tightens Riot Platforms RIOT Surges Over 3 as Momentum Builds Near Key Resistance US Payrolls Surpass Expectations in April but Report Flags Economic Vulnerabilities MSEX Q1 2026 Earnings EPS Falls Short of Estimates as Stock Edges Lower Profound Medical Stock Dips 2 as Shares Test Key Support Levels MTNB Q4 2024 Earnings NarrowerthanExpected Loss Drives Positive Stock Movement OCCIO Q1 2026 Earnings Preferred Stock Reports Negative EPS of 076 Sharply Missing Estimates NTLA Q1 2026 Earnings Narrowerthanexpected loss signals continued progress in gene editing pipeline ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline PERF Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher Datavault AI DVLT Q1 2026 Earnings Miss EPS 009 vs 007 Expected SEER Q1 2026 Earnings Slight EPS Beat Amidst Quiet Revenue Disclosure